Our Services
Hit to Lead Optimization
We offer Hit-to-Lead optimization through structure-based design, flexible docking, and molecular dynamics. Our approach enables rapid prioritization of compounds based on binding affinity, interaction profiles, and key pharmacophoric features.
ADMET
Darcenna provides in silico ADMET prediction to flag liabilities, optimize physicochemical properties, and guide compound selection before preclinical investment. This mitigates downstream risk and informs rational, data-driven design decisions.
Off-target Analysis
We use computational screening to identify potential off-target interactions across transcriptomic and proteomic landscapes. Combining sequence complementarity, structural modeling, and energy profiling, our workflows uncover unintended binding events—critical for improving safety profiles and minimizing adverse effects.
Contact us
Interested in working together? Fill out some info and we will be in touch shortly. We can’t wait to hear from you!